30 Aug
Top 5 Oncology Drugs in the Global Pharmaceutical Industry (2017)
Oncology drugs is one of the fastest-growing segments in the global pharmaceutical industry. Over the next five years, oncology drug sales are expected to exceed USD 90 billion—a staggering number
25 Aug
Novartis Expands Cancer Drugs Portfolio as Kisqali Receives EU Approval
The newest of Novartis’s cancer drugs, Kisqali, has received European Union approval. Kisqali will be used as a first-line treatment for a difficult-to-treat breast cancer. The company expects Kisqali to be a
24 Aug
Top 10 Oncology Drugs Companies (2017)
With cancer rates on the rise, oncology drugs are more valuable and necessary now than ever before. For pharmaceutical companies, oncology drugs are guaranteed to generate revenue—and for patients, oncology
